Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

TERT overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

BRAF mutation + TERT overexpression (2)

CCDC6‐RET fusion + TERT promotor mutation (1)

CDKN2A deletion + CDKN2B deletion + MTAP deletion + TERT mutation (1)

TERT C228T + FGFR3 amplification + FGFR3-TACC3 fusion (1)

TERT mutation + AFP elevation (1)

TERT mutation + EGFR T790M + EGFR exon 20 insertion (1)

TERT mutation + MGMT promoter methylation (1)

TERT positive + PD-L1 expression (1)

TMB-H + TERT promoter mutation (1)

BRAF mutation + TERT overexpression (2)

CCDC6‐RET fusion + TERT promotor mutation (1)

CDKN2A deletion + CDKN2B deletion + MTAP deletion + TERT mutation (1)

TERT C228T + FGFR3 amplification + FGFR3-TACC3 fusion (1)

TERT mutation + AFP elevation (1)

TERT mutation + EGFR T790M + EGFR exon 20 insertion (1)

TERT mutation + MGMT promoter methylation (1)

TERT positive + PD-L1 expression (1)

TMB-H + TERT promoter mutation (1)

›

TERT overexpression	Renal Cell Carcinoma	TERT overexpression	Renal Cell Carcinoma	U0126 Sensitive: D – Preclinical U0126 Sensitive : D	U0126 Sensitive: D – Preclinical U0126 Sensitive : D
TERT overexpression	Solid Tumor	TERT overexpression	Solid Tumor	AST-487 Sensitive: D – Preclinical AST-487 Sensitive : D	AST-487 Sensitive: D – Preclinical AST-487 Sensitive : D